Sean Young

Concurrent <i>CIC</i> mutations, <i>IDH</i> mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

Stephen Yip, Yaron S.N. Butterfield, Olena Morozova et al. · The Journal of Pathology · 2011 · 310 citations · Full text

Medicine, Genetics, Oncology +16

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

Joshua Z. Press, Alessandro De Luca, Niki Boyd et al. · BMC Cancer · 2008 · 286 citations · Full text

Medicine, Genetics, Oncology +17

Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer

Eric Y. Stutheit-Zhao, Yaoqing Shen, Erin Pleasance et al. · Clinical Cancer Research · 2017 · 195 citations

Medicine, Molecular Genetics, Oncology +16

Characterization of a Recurrent Germ Line Mutation of the <i>E-Cadherin</i> Gene: Implications for Genetic Testing and Clinical Management

Gianpaolo Suriano, Sandie Yew, Paulo Michel Pinheiro Ferreira et al. · Clinical Cancer Research · 2005 · 158 citations

Medicine, Genetics, Oncology +17

Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer

Kasmintan A. Schrader, Jane Hurlburt, Steve E. Kalloger et al. · Obstetrics and Gynecology · 2012 · 129 citations

Life Sciences, Genetics, Oncology +17